Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions
Stephen J. Greene(Duke Medical Center), Javed Butler(Jackson Memorial Hospital), Piotr Ponikowski(Wroclaw Medical University), Jasper J. Brugts(Erasmus MC), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Carolyn S.P. Lam(University of Glasgow), Lars H. Lund(Karolinska University Hospital), Adriaan A. Voors(University Medical Center Groningen), Justin A. Ezekowitz(University of Alberta), Shelley Zieroth(University of Manitoba), Johann Bauersachs(Medizinische Hochschule Hannover)
Cited by 269
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k